+1 (855) PLE.XISION (753.9474) info@plexision.com
PERSONALIZED MEDICINE FOR BETTER HEALTH

References

You are here

Home    /    Transplantation    /    PleximmuneTM    /    References

1.        Martin SR, Atkison P, Anand R, Lindblad AS; SPLIT Research Group. Studies of PediatricLiver Transplantation 2002: patient and graft survival and rejection in pediatric recipients of a first livertransplant in the United States and Canada. Pediatr Transplant. 2004 Jun;8(3):273-83. PMID: 15176966.

2.       Grant D. Current results of intestinal transplantation. The International Intestinal TransplantRegistry. Lancet. 1996 Jun 29;347(9018):1801-3.PMID:8667925.

3.       Grant D, Abu-Elmagd K, Reyes J, Tzakis A, Langnas A, Fishbein T, Goulet O, Farmer D; Intestine Transplant Registry. 2003 report of the intestine transplant registry: a new era has dawned. Ann Surg. 2005 Apr;241(4):607-13.PMID:15798462.

4.       Ashokkumar C, Talukdar A, Sun Q, Higgs BW, Janosky J, Wilson P, Mazariegos G, Jaffe R, Demetris A, Dobberstein J, Soltys K, Bond G, Thomson AW, Zeevi A, Sindhi R. Allospecific CD154+ T cells associate with rejection risk after pediatric liver transplantation. Am J Transplant. 2009 Jan;9(1):179-91. Epub 2008 Oct 31. PMID:18976293.

5.       Ashokkumar C, Gupta A, Sun Q, Ningappa MB, Higgs BW, Mazariegos G, Fazzolare T, Remaley L, Soltys K, Bond G, Abu-Elmagd K, Sindhi R.Allospecific CD154+ T cells identify rejection-prone recipients after pediatric small-bowel transplantation.Surgery. 2009 Aug;146(2):166-73. Epub 2009 Jun 26.PMID:19628070.

6.       Sindhi R, Ashokkumar C, Higgs BW, Gilbert PB, Sun Q, Ranganathan S, Jaffe R, Snyder S, Ningappa M, Soltys KA, Bond GJ, Mazariegos GV, Abu-Elmagd K, Zeevi A. Allospecific CD154 + T-cytotoxic memory cells as potential surrogate for rejection risk in pediatric intestine transplantation. Pediatr Transplant. 2012 Feb;16(1):83-91. doi: 10.1111/j.1399-3046.2011.01617.x. Epub 2011 Nov 29. PMID: 22122074

7.       Sindhi R, Ashokkumar C, Higgs BW. Cellular alloresponses for rejection-risk assessment after pediatric transplantation. Curr Opin Organ Transplant. 2011 Oct;16(5):515-21. Review. PMID: 21844808.

8.       Siddharth Sood, Adam G Testro. Immune monitoring post liver transplant. World J Transplant. 2014 March 24; 4(1): 30–39. Published online 2014 March 24. PMCID: PMC3964194

9.       Ashokkumar C, Soltys K, Mazariegos G, Bond G, Higgs BW, Ningappa M, Sun Q, Brown A, White J, Levy S, Fazzolare T, Remaley L, Dirling K, Harris P, Hartle T, Kachmar P, Nicely M, OʼToole L, Boehm B, Jativa N, Stanley P, Jaffe R, Ranganathan S, Zeevi A, Sindhi R. Predicting Cellular Rejection With a Cell-Based Assay: Preclinical Evaluation in Children. Transplantation. 2016 Mar 4. [Epub ahead of print] PMID: 26950712

10.       Sindhi R, Ashokkumar C, Higgs BW, Levy S, Soltys K, Bond G, Mazariegos G, Ranganathan S, Zeevi A. Profile of the Pleximmune blood test for transplant rejection risk prediction. Expert Rev Mol Diagn. 2016 Feb 16:1-9. [Epub ahead of print]. PMID: 26760313

11.       Ranganathan S, Celik N, Mazariegos G, Sindhi R. Liver allograft fibrosis and minimization of immunosuppression. Pediatr Transplant. 2015 Nov;19(7):667-8. doi: 10.1111/petr.12590. Epub 2015 Sep 3. No abstract available. PMID: 26333572